Skip to main content

Advertisement

Table 5 Suggestion for the use of G-CSFs in individual cases. Secondary prevention dosage of G-CSFs

From: A questionnaire survey of pharmacists regarding the clinical practice guidelines for the appropriate use of granulocyte-colony stimulating factors

  Q15. DTX for squamous cell lung cancera
  n = 168
I recommend of secondary prophylactic administration of G-CSFs 73 (43.4)b
After Grade 4 neutropenia developed, I recommend G-CSFs 23 (13.7)
After FN developed, I recommend G-CSFs 6 (3.6)
I do not recommend G-CSFs 66 (39.3)
  1. DTX Docetaxel, G-CSF Granulocyte-Colony Stimulating Factor, FN Febrile Neutropenia
  2. aA 78-year-old man. You diagnosis of lung squamous cell carcinoma and started docetaxel alone therapy, but complication of febrile neutropenia was appeared. You confirmed a good tumor reduction effect, so you plan to treat the second course. What kind of suggestion do you do as a pharmacist?
  3. bNumber (percent)